Oaktree Acquisition Corp. III Life Sciences SEC filings OACCU

Oaktree Acquisition Corp. III Life Sciences has 66 filings in SEC EDGAR's recent list, going back to Aug 7, 2024. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (unregistered share sale, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on December 31.

Oaktree Acquisition Corp. III Life Sciences SEC filings
Form Description Filed Period
8-K Current report
Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
Oct 26, 2026 Oct 23, 2026
8-K Current report
Regulation FD disclosure
Oct 16, 2026 Oct 16, 2026
8-K Current report
Regulation FD disclosure
Oct 15, 2026 Oct 14, 2026
8-K Current report
Officer or director change
Oct 29, 2025 Oct 29, 2025
8-K Current report
Officer or director change
Oct 17, 2025 Oct 17, 2025
8-K Current report
Officer or director change
Jun 6, 2025 Jun 3, 2025
8-K Current report
Officer or director change
Jan 7, 2025 Jan 6, 2025
8-K Current report
Other events
Dec 11, 2024 Dec 11, 2024
8-K Current report
Unregistered share sale, Other events
Nov 5, 2024 Oct 30, 2024
8-K Current report
Other events
Oct 31, 2024 Oct 25, 2024
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Oct 25, 2024 Oct 23, 2024

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Blank Checks (SIC 6770)
Listed as
OACC (Nasdaq), OACCU (Nasdaq), OACCW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Los Angeles, CA
SEC filer status
, Emerging growth company
SEC CIK
2029769

Other Blank Checks companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.